Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation-Reference-Cited by-同舟云学术

Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation

Published:2014-02-07 Issue:29 Volume:35 Page:1949-1956
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Silber S.,Kirtane A. J.,Belardi J. A.,Liu M.,Brar S.,Rothman M.,Windecker S.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/35/29/1949/6730881/ehu026.pdf

Reference51 articles.

1. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy

2. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents

3. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents

4. A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

5. A Cause for Concern

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and chances coexist: A visualized analysis and bibliometric study of research on bioresorbable vascular scaffolds from 2000 to 2022;Medicine;2023-05-26

2. A technology evaluation of the Onyx Frontier drug-eluting stent;Expert Opinion on Drug Delivery;2023-05-04

3. Durable Polymer Everolimus Eluting Stents;Interventional Cardiology;2022-05-06

4. Zotarolimus‐Eluting Stents;Interventional Cardiology;2022-05-06

5. The Mechanisms of Restenosis and Relevance to Next Generation Stent Design;Biomolecules;2022-03-10